51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT2051200133	31/03/2021	12/02/2021	A study of Guselkumab in Participants with Systemic Sclerosis	A Multicenter, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Study of Guselkumabin ...	Scleroderma, Systemic	Group A: GuselkumabDose 1 GuselkumabDose 1 will be administered intravenously. Group A: GuselkumabDose ...	Numaguchi Hirotaka	NULL	Recruiting	>= 18age old	<= 75age old	Both	56	Phase 2	Japan
2	NCT04683029 (ClinicalTrials.gov)	February 24, 2021	22/12/2020	A Study of Guselkumab in Participants With Systemic Sclerosis	A Multicenter, Randomized, Placebo-controlled, Double-blind, Proof-of-concept Study of Guselkumabin ...	Scleroderma, Systemic	Drug: Guselkumab Dose 1;Drug: Guselkumab Dose 2;Drug: Placebo	Janssen Pharmaceutical K.K.	NULL	Recruiting	18 Years	75 Years	All	56	Phase 2	Japan

First Previous1Next Last